- Home
- IMMP vs NAUT Comparison
IMMP vs NAUT Comparison
Compare IMMP & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- NAUT
- Stock Information
- Founded
- IMMP 1987
- NAUT 2016
- Country
- IMMP Australia
- NAUT United States
- Employees
- IMMP N/A
- NAUT N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- IMMP Health Care
- NAUT Industrials
- Exchange
- IMMP Nasdaq
- NAUT Nasdaq
- Market Cap
- IMMP 304.0M
- NAUT 284.7M
- IPO Year
- IMMP N/A
- NAUT N/A
- Fundamental
- Price
- IMMP $2.17
- NAUT $1.81
- Analyst Decision
- IMMP Buy
- NAUT Hold
- Analyst Count
- IMMP 2
- NAUT 3
- Target Price
- IMMP $8.50
- NAUT $3.58
- AVG Volume (30 Days)
- IMMP 147.6K
- NAUT 132.0K
- Earning Date
- IMMP 12-27-2024
- NAUT 10-29-2024
- Dividend Yield
- IMMP N/A
- NAUT N/A
- EPS Growth
- IMMP N/A
- NAUT N/A
- EPS
- IMMP N/A
- NAUT N/A
- Revenue
- IMMP $2,563,302.00
- NAUT N/A
- Revenue This Year
- IMMP N/A
- NAUT N/A
- Revenue Next Year
- IMMP $10.84
- NAUT N/A
- P/E Ratio
- IMMP N/A
- NAUT N/A
- Revenue Growth
- IMMP 9.59
- NAUT N/A
- 52 Week Low
- IMMP $1.66
- NAUT $1.80
- 52 Week High
- IMMP $3.34
- NAUT $3.46
- Technical
- Relative Strength Index (RSI)
- IMMP 55.07
- NAUT 32.10
- Support Level
- IMMP $2.00
- NAUT $1.88
- Resistance Level
- IMMP $2.39
- NAUT $2.21
- Average True Range (ATR)
- IMMP 0.13
- NAUT 0.16
- MACD
- IMMP 0.01
- NAUT -0.02
- Stochastic Oscillator
- IMMP 54.17
- NAUT 2.33
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.